ArticleInflammatory bowel diseases2020

Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease.

Laura E Bauman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.